OCC 4.11% 35.0¢ orthocell limited

Ann: Quarterly Activity Report & Appendix 4C, page-17

  1. 541 Posts.
    lightbulb Created with Sketch. 32
    Forgive me for being an idiot but ... but would someone please explain to me the significant difference between the cash receipts and reported revenue?

    4C reported cash receipts for Q3 FY24 is $645k.  
    Management commentary "revenue for Q3FY24 $1.61million"

    I have a basic understanding of cash versus accrual accounting, so I get that there may be a lag between booking a sale and actually receiving the payment. But I still can't get my head around this:


    FY23 Q1-Q4 cash receipts from customers:  $1.873m
    FY23 Q1-Q4 revenue (see Figure page 2): $5.512m


    FY24 YTD Q3 cash receipts from customers:  $2.438m
    FY24 YTD Q3 revenue (see Figure 1 page 2): $4.908m



    So, for 7 quarters, FY23 + FY 24 YTD Q3

    "Cash Receipts" (4C) :  $1.873m + 2.438m = $4.311 million
    "Revenue" (Figure 2) : $5.512m + 4.908m = $10.060 million.

    Where's the missing $5.7m difference? That's a big chunk of accounts payable.....





 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
35.0¢
Change
-0.015(4.11%)
Mkt cap ! $73.26M
Open High Low Value Volume
36.5¢ 36.5¢ 35.0¢ $68.55K 192.0K

Buyers (Bids)

No. Vol. Price($)
8 107444 35.0¢
 

Sellers (Offers)

Price($) Vol. No.
35.5¢ 8000 2
View Market Depth
Last trade - 16.10pm 05/06/2024 (20 minute delay) ?
Last
35.5¢
  Change
-0.015 ( 2.74 %)
Open High Low Volume
36.0¢ 36.0¢ 35.5¢ 86639
Last updated 15.54pm 05/06/2024 ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.